Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study - CNRS - Centre national de la recherche scientifique Access content directly
Journal Articles Alimentary Pharmacology & Therapeutics (Suppl) Year : 2020

Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study

Pietro Lampertico
Thomas Berg
  • Function : Author
Maria Buti
Anita Pathil
  • Function : Author
Joerg Petersen
  • Function : Author
Stephen Ryder
  • Function : Author
Irina Botros
  • Function : Author
John Flaherty
  • Function : Author
Belinda Jump
  • Function : Author
Marjoleine Op den Brouw
  • Function : Author
Anna van Troostenburg
  • Function : Author
Heribert Ramroth
  • Function : Author

Domains

Cancer

Dates and versions

hal-03933002 , version 1 (10-01-2023)

Identifiers

Cite

Pietro Lampertico, Thomas Berg, Maria Buti, Anita Pathil, Joerg Petersen, et al.. Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study. Alimentary Pharmacology & Therapeutics (Suppl), 2020, 52 (3), pp.500-512. ⟨10.1111/apt.15901⟩. ⟨hal-03933002⟩
7 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More